# West Bancorporation Inc: financial statements, quarterly

WTBA · Nasdaq · CIK 1166928 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wtba.md) · [Financials](/companies/wtba/financials.md) · [Filings](/companies/wtba/filings.md) · [Insiders](/companies/wtba/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wtba/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [26.3 d](/filings/0001166928-24-000024.md) | [27.8](/filings/0001166928-24-000052.md) | [30.3](/filings/0001166928-24-000089.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.1 d](/filings/0001166928-26-000010.md) | [1.4](/filings/0001166928-25-000034.md) | [1.2](/filings/0001166928-25-000068.md) | [1.5](/filings/0001166928-25-000081.md) | [(0.6) d](/filings/0001166928-26-000010.md) | [2.2](/filings/0001166928-26-000023.md) | [2.4](/filings/0001166928-26-000034.md) | [2.1](/filings/0001166928-26-000042.md) | [2.2 d](/filings/0001166928-26-000010.md) | [2.9](/filings/0001166928-26-000023.md) | [3.3](/filings/0001166928-26-000034.md) | [3.5](/filings/0001166928-26-000042.md) |
| Net income | $m | [4.5 d](/filings/0001166928-26-000010.md) | [5.8](/filings/0001166928-25-000034.md) | [5.2](/filings/0001166928-25-000068.md) | [6.0](/filings/0001166928-25-000081.md) | [7.1 d](/filings/0001166928-26-000010.md) | [7.8](/filings/0001166928-26-000023.md) | [8.0](/filings/0001166928-26-000034.md) | [9.3](/filings/0001166928-26-000042.md) | [7.4 d](/filings/0001166928-26-000010.md) | [10.6](/filings/0001166928-26-000023.md) | [11.1](/filings/0001166928-26-000034.md) | [11.6](/filings/0001166928-26-000042.md) |
| Diluted EPS | $ per share | not reported | [0.35](/filings/0001166928-25-000034.md) | [0.31](/filings/0001166928-25-000068.md) | [0.35](/filings/0001166928-25-000081.md) | not reported | [0.46](/filings/0001166928-26-000023.md) | [0.47](/filings/0001166928-26-000034.md) | [0.55](/filings/0001166928-26-000042.md) | not reported | [0.61](/filings/0001166928-26-000023.md) | [0.64](/filings/0001166928-26-000034.md) | [0.67](/filings/0001166928-26-000042.md) |
| Basic EPS | $ per share | not reported | [0.35](/filings/0001166928-25-000034.md) | [0.31](/filings/0001166928-25-000068.md) | [0.35](/filings/0001166928-25-000081.md) | not reported | [0.47](/filings/0001166928-26-000023.md) | [0.47](/filings/0001166928-26-000034.md) | [0.55](/filings/0001166928-26-000042.md) | not reported | [0.62](/filings/0001166928-26-000023.md) | [0.65](/filings/0001166928-26-000034.md) | [0.68](/filings/0001166928-26-000042.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,826](/filings/0001166928-25-000012.md) | [3,963](/filings/0001166928-24-000052.md) | [3,965](/filings/0001166928-24-000089.md) | [3,989](/filings/0001166928-24-000107.md) | [4,015](/filings/0001166928-26-000010.md) | [3,987](/filings/0001166928-25-000034.md) | [4,057](/filings/0001166928-25-000068.md) | [3,985](/filings/0001166928-25-000081.md) | [4,142](/filings/0001166928-26-000042.md) | [4,011](/filings/0001166928-26-000023.md) | [4,030](/filings/0001166928-26-000034.md) | [3,892](/filings/0001166928-26-000042.md) |
| Total liabilities | $m | [3,601](/filings/0001166928-25-000012.md) | [3,739](/filings/0001166928-24-000052.md) | [3,741](/filings/0001166928-24-000089.md) | [3,753](/filings/0001166928-24-000107.md) | [3,787](/filings/0001166928-26-000010.md) | [3,749](/filings/0001166928-25-000034.md) | [3,816](/filings/0001166928-25-000068.md) | [3,730](/filings/0001166928-25-000081.md) | [3,876](/filings/0001166928-26-000042.md) | [3,740](/filings/0001166928-26-000023.md) | [3,749](/filings/0001166928-26-000034.md) | [3,620](/filings/0001166928-26-000042.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [225](/filings/0001166928-26-000010.md) | [224](/filings/0001166928-25-000068.md) | [224](/filings/0001166928-25-000081.md) | [235](/filings/0001166928-25-000081.md) | [228](/filings/0001166928-26-000042.md) | [238](/filings/0001166928-26-000034.md) | [241](/filings/0001166928-26-000042.md) | [255](/filings/0001166928-26-000042.md) | [266](/filings/0001166928-26-000042.md) | [271](/filings/0001166928-26-000034.md) | [281](/filings/0001166928-26-000042.md) | [272](/filings/0001166928-26-000042.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.2 d](/filings/0001166928-26-000010.md) | [6.1](/filings/0001166928-25-000034.md) | [10.0 d](/filings/0001166928-25-000068.md) | [12.9 d](/filings/0001166928-25-000081.md) | [10.8 d](/filings/0001166928-26-000010.md) | [9.7](/filings/0001166928-26-000023.md) | [13.5 d](/filings/0001166928-26-000034.md) | [11.4 d](/filings/0001166928-26-000042.md) | [11.8 d](/filings/0001166928-26-000010.md) | [12.9](/filings/0001166928-26-000023.md) | [14.4 d](/filings/0001166928-26-000034.md) | [15.7 d](/filings/0001166928-26-000042.md) |
| Capital expenditure | $m | [11.7 d](/filings/0001166928-26-000010.md) | [10.3](/filings/0001166928-25-000034.md) | [7.3 d](/filings/0001166928-25-000068.md) | [6.0 d](/filings/0001166928-25-000081.md) | [2.6 d](/filings/0001166928-26-000010.md) | [1.5](/filings/0001166928-26-000023.md) | [0.8 d](/filings/0001166928-26-000034.md) | [0.6 d](/filings/0001166928-26-000042.md) | [0.4 d](/filings/0001166928-26-000010.md) | [0.5](/filings/0001166928-26-000023.md) | [0.3 d](/filings/0001166928-26-000034.md) | [0.1 d](/filings/0001166928-26-000042.md) |
| Dividends paid | $m | [4.2 d](/filings/0001166928-26-000010.md) | [4.2](/filings/0001166928-25-000034.md) | [4.2 d](/filings/0001166928-25-000068.md) | [4.2 d](/filings/0001166928-25-000081.md) | [4.2 d](/filings/0001166928-26-000010.md) | [4.2](/filings/0001166928-26-000023.md) | [4.2 d](/filings/0001166928-26-000034.md) | [4.2 d](/filings/0001166928-26-000042.md) | [4.2 d](/filings/0001166928-26-000010.md) | [4.2](/filings/0001166928-26-000023.md) | [4.3 d](/filings/0001166928-26-000034.md) | [4.4 d](/filings/0001166928-26-000042.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.8](/filings/0001166928-24-000052.md) | [16.8](/filings/0001166928-24-000089.md) | [16.8](/filings/0001166928-24-000107.md) | [16.8](/filings/0001166928-25-000034.md) | [16.8](/filings/0001166928-25-000068.md) | [16.9](/filings/0001166928-25-000081.md) | [17.1](/filings/0001166928-26-000023.md) | [17.0](/filings/0001166928-26-000034.md) | [17.0](/filings/0001166928-26-000042.md) | [17.2](/filings/0001166928-26-000023.md) | [17.2](/filings/0001166928-26-000034.md) | [17.3](/filings/0001166928-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,043,743 at 2026-10-28, from the cover of the [10-Q filed 2026-10-29](/filings/0001166928-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 07:27 ET. No prices; not investment advice.